Match!
María Cespón-Fernández
3Publications
1H-index
1Citations
Publications 3
Newest
Published on May 1, 2019in Revista Espanola De Cardiologia5.13
Sergio Raposeiras-Roubín13
Estimated H-index: 13
,
Emad Abu Assi16
Estimated H-index: 16
+ 46 AuthorsRafael Cobas-Paz1
Estimated H-index: 1
Abstract Introduction and objectives For patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI), it is unclear whether angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) are associated with reduced mortality, particularly with preserved left ventricular ejection fraction (LVEF). The goal of this study was to determine the association between ACEI/ARB and mortality in ACS patients undergoing PCI, with and without reduc...
Published on Mar 28, 2019in American Journal of Cardiovascular Drugs2.58
María Cespón-Fernández1
Estimated H-index: 1
,
Sergio Raposeiras-Roubín13
Estimated H-index: 13
+ 17 AuthorsBerenice Caneiro-Queija1
Estimated H-index: 1
Introduction The goal of this study was to determine the association between the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) and follow-up heart failure (HF) according to left ventricular ejection fraction (LVEF) in patients with acute myocardial infarction (AMI).
Published on Feb 1, 2019in Thrombosis Research3.27
Sergio Raposeiras-Roubín13
Estimated H-index: 13
,
Emad Abu Assi16
Estimated H-index: 16
+ 10 AuthorsMaría Castiñeira-Busto5
Estimated H-index: 5
Abstract Introduction There are conflicting clinical and laboratory data about the effect of dual antiplatelet therapy (DAPT) on cancer incidence, including analysis suggesting an increased cancer risk. This study aims to analyze if there are differences in the incidence of cancer according to the type of P2Y12 inhibitor prescribed (clopidogrel, prasugrel, or ticagrelor), among a population of acute coronary syndrome (ACS) survivors treated with DAPT. Material and methods A retrospective study w...
Sergio Raposeiras-Roubín13
Estimated H-index: 13
,
Emad Abu Assi16
Estimated H-index: 16
+ -3 AuthorsRafael Cobas-Paz1
Estimated H-index: 1
Resumen Introduccion y objetivos No esta clara la asociacion entre los inhibidores de la enzima de conversion de la angiotensina (IECA) o los antagonistas del receptor de la angiotensina II (ARA-II) y la mortalidad de los pacientes con sindrome coronario agudo (SCA) sometidos a intervencion coronaria percutanea (ICP) con fraccion de eyeccion del ventriculo izquierdo (FEVI) conservada. Nuestro objetivo es determinar dicha asociacion en pacientes con FEVI conservada o reducida. Metodos Se analizar...
1